Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer. [electronic resource]
Producer: 20141121Description: 199-207 p. digitalISSN:- 1551-4005
- Carcinoma, Ovarian Epithelial
- Cell Line, Tumor
- Cell Proliferation
- Cellular Senescence
- DNA Damage
- Epithelium -- enzymology
- Fallopian Tubes -- enzymology
- Female
- Gene Knockdown Techniques
- Humans
- Ki-67 Antigen -- metabolism
- Middle Aged
- Molecular Targeted Therapy
- Neoplasm Grading
- Neoplasm Staging
- Neoplasms, Glandular and Epithelial -- enzymology
- Ovarian Neoplasms -- enzymology
- Ovary -- enzymology
- Ribonucleoside Diphosphate Reductase -- genetics
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.